Autor: "Wang, Zhou" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Overexpression of JAB1 promotes malignant behavior and predicts poor prognosis in esophageal squamous cell carcinoma.
Autorzy:: Shen Q; Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Shang B; Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Jiang B; Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Wang Y; Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Wang Z; Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Chen G; Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2020 Apr; Vol. 11 (4), pp. 973-982. Date of Electronic Publication: 2020 Feb 16.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Biomarkers, Tumor/*metabolism
COP9 Signalosome Complex/*metabolism
Esophageal Neoplasms/*pathology
Esophageal Squamous Cell Carcinoma/*pathology
Intracellular Signaling Peptides and Proteins/*metabolism
Peptide Hydrolases/*metabolism
Animals ; Apoptosis ; Biomarkers, Tumor/genetics ; COP9 Signalosome Complex/genetics ; Cell Movement ; Cell Proliferation ; Esophageal Neoplasms/genetics ; Esophageal Neoplasms/metabolism ; Esophageal Squamous Cell Carcinoma/genetics ; Esophageal Squamous Cell Carcinoma/metabolism ; Humans ; Intracellular Signaling Peptides and Proteins/genetics ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Neoplasm Invasiveness ; Peptide Hydrolases/genetics ; Prognosis ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: FOXM1: A potential indicator to predict lymphatic metastatic recurrence in stage IIA esophageal squamous cell carcinoma.
Autorzy:: Xiao Z; Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Jia Y; Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Jiang W; Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Wang Z; Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Zhang Z; Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.; Department of Thoracic Surgery, Jinan Central Hospital Affiliated to Shandong University, Jinan, China.
Gao Y; Department of Gynaecology and Obstetrics, Jining Traditional Chinese Medicine Hospital, Jining, China.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2018 Aug; Vol. 9 (8), pp. 997-1004. Date of Electronic Publication: 2018 Jun 06.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Up-Regulation*
Esophageal Neoplasms/*pathology
Esophageal Squamous Cell Carcinoma/*pathology
Forkhead Box Protein M1/*metabolism
Lymphatic Metastasis/*diagnosis
Biomarkers, Tumor/metabolism ; Esophageal Neoplasms/metabolism ; Esophageal Squamous Cell Carcinoma/metabolism ; Female ; Humans ; Male ; Neoplasm Staging ; Prognosis ; Survival Analysis ; Tumor Burden

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Clinical and prognostic significance of MUC1 expression in patients with esophageal squamous cell carcinoma after radical resection.
Autorzy:: Sun ZG; Department of Thoracic Surgery, Jinan Central Hospital Affiliated to Shandong University, Shandong University, Jinan, Shandong Province, China.
Yu L; Department of Otorhinolaryngology, Jinan Central Hospital Affiliated to Shandong University, Shandong University, Jinan, Shandong Province, China.
Gao W; Department of Pathology, Jinan Central Hospital Affiliated to Shandong University, Shandong University, Jinan, Shandong Province, China.
Wang Z; Provincial Hospital Affiliated to Shandong University, Jinan, Shandong Province, China.
Zhu LM; Department of Thoracic Surgery, Jinan Central Hospital Affiliated to Shandong University, Shandong University, Jinan, Shandong Province, China.; Pokaż więcej
Źródło:: Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association [Saudi J Gastroenterol] 2018 May-Jun; Vol. 24 (3), pp. 165-170.
Typ publikacji:: Journal Article
MeSH Terms:: Up-Regulation*
Carcinoma, Squamous Cell/*surgery
Esophageal Neoplasms/*surgery
Mucin-1/*genetics
Mucin-1/*metabolism
Carcinoma, Squamous Cell/genetics ; Carcinoma, Squamous Cell/metabolism ; Carcinoma, Squamous Cell/pathology ; Esophageal Neoplasms/genetics ; Esophageal Neoplasms/metabolism ; Esophageal Neoplasms/pathology ; Esophageal Squamous Cell Carcinoma ; Esophagectomy ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Lymphatic Metastasis ; Male ; Neoplasm Staging ; Prognosis ; Survival Analysis ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Overexpression of IFITM3 predicts poor prognosis in stage IIA esophageal squamous cell carcinoma after Ivor Lewis esophagectomy.
Autorzy:: Jia Y; Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Xiao Z; Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Jiang W; Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Chen G; Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Wang Z; Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2017 Nov; Vol. 8 (6), pp. 592-599. Date of Electronic Publication: 2017 Aug 30.
Typ publikacji:: Journal Article
MeSH Terms:: Up-Regulation*
Carcinoma, Squamous Cell/*pathology
Carcinoma, Squamous Cell/*surgery
Esophageal Neoplasms/*pathology
Esophageal Neoplasms/*surgery
Esophagectomy/*methods
Membrane Proteins/*metabolism
RNA-Binding Proteins/*metabolism
Adult ; Aged ; Carcinoma, Squamous Cell/metabolism ; Esophageal Neoplasms/metabolism ; Esophageal Squamous Cell Carcinoma ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Prognosis ; Survival Analysis ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: RUNX3 reverses cisplatin resistance in esophageal squamous cell carcinoma via suppression of the protein kinase B pathway.
Autorzy:: Li DJ; Department of ICU, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Shi M; Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Wang Z; Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2016 Sep; Vol. 7 (5), pp. 570-580. Date of Electronic Publication: 2016 Jun 20.
Typ publikacji:: Journal Article
MeSH Terms:: Drug Resistance, Neoplasm*
Carcinoma, Squamous Cell/*drug therapy
Carcinoma, Squamous Cell/*surgery
Cisplatin/*administration & dosage
Core Binding Factor Alpha 3 Subunit/*metabolism
Esophageal Neoplasms/*drug therapy
Esophageal Neoplasms/*surgery
Proto-Oncogene Proteins c-akt/*metabolism
Animals ; Apoptosis ; Carcinoma, Squamous Cell/metabolism ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Chemotherapy, Adjuvant ; Cisplatin/pharmacology ; Esophageal Neoplasms/metabolism ; Esophageal Squamous Cell Carcinoma ; Esophagectomy ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Male ; Mice ; Neoplasm Transplantation ; Signal Transduction

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations.
Autorzy:: Wu C; State Key Laboratory of Molecular Oncology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang Z; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA.; Cancer Genome Research Laboratory, Division of Cancer Epidemiology and Genetics, Advanced Technology Program, SAIC-Frederick Inc., NCI-Frederick, Frederick, MD, USA.
Song X; Department of Pathology, Cancer Research Center, Basic Medical College, Xinxiang Medical University, Xinxiang, Henan, China.; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Feng XS; Department of Oncology, Pathology, Clinical Laboratory and Respiratory Medicine, The First Affiliated Hospital, Henan University of Science and Technology, Luoyang, Henan, China.
Abnet CC; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA.
He J; Department of Thoracic Surgery, Cancer Institute & Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Hu N; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA.
Zuo XB; Key Laboratory of Dermatology, Anhui Medical University, Anhui, Hefei, China.
Tan W; State Key Laboratory of Molecular Oncology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zhan Q; State Key Laboratory of Molecular Oncology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Hu Z; Department of Epidemiology and Biostatistics, Cancer Center, Nanjing Medical University, Nanjing, China.
He Z; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China.
Jia W; State Key Laboratory of Oncology in Southern China.; Department of Experimental Research, Sun Yat-Sen University Cancer Center, Guangzhou, China.
Zhou Y; Laboratory of Cancer Molecular Genetics, Medical College of Soochow University, Suzhou, China.
Yu K; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA.
Shu XO; Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA.; Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee, USA.
Yuan JM; University of Pittsburgh Cancer Institute, Pittsburg, PA, USA.
Zheng W; Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA.; Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee, USA.
Zhao XK; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Gao SG; Department of Oncology, Pathology, Clinical Laboratory and Respiratory Medicine, The First Affiliated Hospital, Henan University of Science and Technology, Luoyang, Henan, China.
Yuan ZQ; Department of Pathology, Cancer Research Center, Basic Medical College, Xinxiang Medical University, Xinxiang, Henan, China.
Zhou FY; Anyang Tumor Hospital, Anyang, Henan, China.
Fan ZM; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Cui JL; Department of Pathology, Cancer Research Center, Basic Medical College, Xinxiang Medical University, Xinxiang, Henan, China.; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Lin HL; Department of Pathology, Cancer Research Center, Basic Medical College, Xinxiang Medical University, Xinxiang, Henan, China.; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Han XN; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Li B; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Chen X; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.; Department of Basic Oncology and Pathology at College of Medicine, Zhengzhou University, Zhengzhou, Henan, China.
Dawsey SM; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA.
Liao L; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA.
Lee MP; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Ding T; Shanxi Cancer Hospital, Taiyuan, Shanxi, China.
Qiao YL; Department of Epidemiology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Liu Z; State Key Laboratory of Molecular Oncology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Liu Y; State Key Laboratory of Molecular Oncology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yu D; State Key Laboratory of Molecular Oncology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Chang J; State Key Laboratory of Molecular Oncology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wei L; State Key Laboratory of Molecular Oncology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Gao YT; Shanghai Cancer Institute, Shanghai, People's Republic of China.
Koh WP; Duke-National University of Singapore, Graduate Medical School, Singapore.
Xiang YB; Shanghai Cancer Institute, Shanghai, People's Republic of China.
Tang ZZ; Shanxi Cancer Hospital, Taiyuan, Shanxi, China.
Fan JH; Department of Epidemiology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Han JJ; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.; Department of Basic Oncology and Pathology at College of Medicine, Zhengzhou University, Zhengzhou, Henan, China.
Zhou SL; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Zhang P; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Zhang DY; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Yuan Y; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Huang Y; State Key Laboratory of Molecular Oncology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Liu C; State Key Laboratory of Molecular Oncology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zhai K; State Key Laboratory of Molecular Oncology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Qiao Y; State Key Laboratory of Molecular Oncology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jin G; Department of Epidemiology and Biostatistics, Cancer Center, Nanjing Medical University, Nanjing, China.
Guo C; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China.
Fu J; State Key Laboratory of Oncology in Southern China.; Department of Experimental Research, Sun Yat-Sen University Cancer Center, Guangzhou, China.
Miao X; Key Laboratory for Environment and Health (Ministry of Education), School of Public Health, Huazhong University of Sciences and Technology, Wuhan, China.
Lu C; Anyang Tumor Hospital, Anyang, Henan, China.
Yang H; Anyang Tumor Hospital, Anyang, Henan, China.
Wang C; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA.
Wheeler WA; Information Management Services Inc., Silver Spring, Maryland, USA.
Gail M; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA.
Yeager M; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA.; Cancer Genome Research Laboratory, Division of Cancer Epidemiology and Genetics, Advanced Technology Program, SAIC-Frederick Inc., NCI-Frederick, Frederick, MD, USA.
Yuenger J; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA.; Cancer Genome Research Laboratory, Division of Cancer Epidemiology and Genetics, Advanced Technology Program, SAIC-Frederick Inc., NCI-Frederick, Frederick, MD, USA.
Guo ET; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Li AL; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.; Department of Medical Oncology, Tumor Hospital of Linzhou, Linzhou, Henan, China.
Zhang W; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Li XM; Department of Pathology and Thoracic Surgery, Centre for Health Screening and Endoscopy, Cixian Hospital, Cixian, Hebei, China.
Sun LD; Key Laboratory of Dermatology, Anhui Medical University, Anhui, Hefei, China.
Ma BG; Department of Gastroenterology, Henan Provincial People's Hospital, Zhengzhou, Henan, China.; Department of Hematology, Henan Provincial People's Hospital, Zhengzhou, Henan, China.; Central Laboratory, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
Li Y; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Tang S; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Peng XQ; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.; Department of Oncology, Pathology, Clinical Laboratory and Respiratory Medicine, The First Affiliated Hospital, Henan University of Science and Technology, Luoyang, Henan, China.
Liu J; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Hutchinson A; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA.; Cancer Genome Research Laboratory, Division of Cancer Epidemiology and Genetics, Advanced Technology Program, SAIC-Frederick Inc., NCI-Frederick, Frederick, MD, USA.
Jacobs K; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA.; Cancer Genome Research Laboratory, Division of Cancer Epidemiology and Genetics, Advanced Technology Program, SAIC-Frederick Inc., NCI-Frederick, Frederick, MD, USA.
Giffen C; Information Management Services Inc., Silver Spring, Maryland, USA.
Burdette L; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA.; Cancer Genome Research Laboratory, Division of Cancer Epidemiology and Genetics, Advanced Technology Program, SAIC-Frederick Inc., NCI-Frederick, Frederick, MD, USA.
Fraumeni JF Jr; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA.
Shen H; Department of Epidemiology and Biostatistics, Cancer Center, Nanjing Medical University, Nanjing, China.
Ke Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China.
Zeng Y; State Key Laboratory of Oncology in Southern China.; Department of Experimental Research, Sun Yat-Sen University Cancer Center, Guangzhou, China.
Wu T; Key Laboratory for Environment and Health (Ministry of Education), School of Public Health, Huazhong University of Sciences and Technology, Wuhan, China.
Kraft P; Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA.
Chung CC; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA.; Cancer Genome Research Laboratory, Division of Cancer Epidemiology and Genetics, Advanced Technology Program, SAIC-Frederick Inc., NCI-Frederick, Frederick, MD, USA.
Tucker MA; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA.
Hou ZC; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Liu YL; Department of Pathology, Cancer Research Center, Basic Medical College, Xinxiang Medical University, Xinxiang, Henan, China.; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Hu YL; Department of Pathology, Cancer Research Center, Basic Medical College, Xinxiang Medical University, Xinxiang, Henan, China.; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Liu Y; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Wang L; Department of Pathology, Cancer Research Center, Basic Medical College, Xinxiang Medical University, Xinxiang, Henan, China.; Department of Basic Oncology, Pathology and Gastroenterology, The Second Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Yuan G; Department of Pathology, Cancer Research Center, Basic Medical College, Xinxiang Medical University, Xinxiang, Henan, China.; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Chen LS; Department of Pathology, Cancer Research Center, Basic Medical College, Xinxiang Medical University, Xinxiang, Henan, China.; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Liu X; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Ma T; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Meng H; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Sun L; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Li XM; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Li XM; Department of Pathology, Cancer Research Center, Basic Medical College, Xinxiang Medical University, Xinxiang, Henan, China.
Ku JW; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.; Department of Oncology, The Second Affiliated Hospital of Nanyang Medical College, Nanyang, Henan, China.
Zhou YF; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.; Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA.
Yang LQ; Department of Radiotherapy, Pathology and Pediatrics, Central Hospital of Xinxiang, Xinxiang, Henan, China.
Wang Z; Department of Thoracic Surgery, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China.
Li Y; Department of Thoracic Surgery and Radiotherapy, Cancer Hospital of Henan Province, Zhengzhou, Henan, China.
Qige Q; Department of Internal Mongolia Medicine, The Affiliated Hospital, Inner Mongolia Medical College, Huhhot, Inner Mongolia, China.
Yang WJ; Department of Biotechnology, Ningxia Medical University, Yinchuan, Ningxia, China.
Lei GY; Department of Thoracic Surgery, Tumor Hospital of Shaanxi Province, Xi'an, Shaanxi, China.
Chen LQ; Department of Thoracic and Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Li EM; Department of Oncologic Pathology, Medical College of Shantou University, Shantou, Guangdong, China.; Department of Biochemistry and Molecular Biology, Medical College of Shantou University, Shantou, Guangdong, China.
Yuan L; Department of Thoracic Surgery and Radiotherapy, Cancer Hospital of Henan Province, Zhengzhou, Henan, China.
Yue WB; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.; Department of Oncology, Puyang City Oil Field General Hospital, Puyang, Henan, China.
Wang R; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Wang LW; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Fan XP; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Zhu FH; Department of Radiotherapy, Pathology and Pediatrics, Central Hospital of Xinxiang, Xinxiang, Henan, China.
Zhao WX; Department of Pathology, Cancer Research Center, Basic Medical College, Xinxiang Medical University, Xinxiang, Henan, China.
Mao YM; Department of Oncology, Pathology, Clinical Laboratory and Respiratory Medicine, The First Affiliated Hospital, Henan University of Science and Technology, Luoyang, Henan, China.
Zhang M; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Xing GL; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Li JL; Department of Pathology and Thoracic Surgery, Linzhou Esophageal Cancer Hospital, Linzhou, Henan, China.
Han M; Department of Gastroenterology and Thoracic Surgery, The First People's Hospital of Shangqiu, Shangqiu, Henan, China.
Ren JL; Department of Basic Oncology, Pathology and Gastroenterology, The Second Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Liu B; Department of Gastroenterology, Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing, China.
Ren SW; Department of Oncology, Xinyang Central Hospital, Xinyang, Henan, China.
Kong QP; State Key Laboratory of Genetic Resource and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China.
Li F; Department of Pathology, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Sheyhidin I; Department of Thoracic Surgery, Xinjiang Medical University, Urumqi, Xinjiang, China.; Medical Research Center, The First Affiliated Hospital, Xinjiang Medical University, Urumqi, Xinjiang, China.
Wei W; Institute of Hematologic Disease, Changzhi Medical University, Changzhi, Shanxi, China.; Department of Pathology, Changzhi Medical University, Changzhi, Shanxi, China.
Zhang YR; Department of Gastroenterology, Henan Provincial People's Hospital, Zhengzhou, Henan, China.; Department of Hematology, Henan Provincial People's Hospital, Zhengzhou, Henan, China.; Central Laboratory, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
Feng CW; Department of Basic Oncology, Pathology and Gastroenterology, The Second Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Wang J; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Yang YH; Department of Surgery, Hebi Dahejian Hospital, Hebi, Henan, China.
Hao HZ; Anyang District Hospital, Anyang, Henan, China.
Bao QD; Anyang District Hospital, Anyang, Henan, China.
Liu BC; Surgical Department of Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Wu AQ; Department of Anatomy, the Second Military Medical University of Chinese PLA, Shanghai, China.
Xie D; Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
Yang WC; Department of Pathology, Cancer Research Center, Basic Medical College, Xinxiang Medical University, Xinxiang, Henan, China.
Wang L; Department of Pathology, Cancer Research Center, Basic Medical College, Xinxiang Medical University, Xinxiang, Henan, China.; Medical College of Wisconsin, Cancer Research Center, Milwaukee, WI, USA.
Zhao XH; National Laboratory of Molecular Oncology, Cancer Institute & Hospital, CAMS, Beijing, China.
Chen SQ; College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China.
Hong JY; College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China.; University of Medicine and Dentistry of New Jersey, Newark, NJ, USA.
Zhang XJ; Key Laboratory of Dermatology, Anhui Medical University, Anhui, Hefei, China.
Freedman ND; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA.
Goldstein AM; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA.
Lin D; State Key Laboratory of Molecular Oncology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Taylor PR; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA.
Wang LD; Department of Pathology, Cancer Research Center, Basic Medical College, Xinxiang Medical University, Xinxiang, Henan, China.; Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA.; Pokaż więcej
Źródło:: Nature genetics [Nat Genet] 2014 Sep; Vol. 46 (9), pp. 1001-1006. Date of Electronic Publication: 2014 Aug 17.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Asian People/*genetics
Carcinoma, Squamous Cell/*genetics
Esophageal Neoplasms/*genetics
Alleles ; Case-Control Studies ; Esophageal Squamous Cell Carcinoma ; Female ; Genetic Loci ; Genetic Predisposition to Disease ; Genome-Wide Association Study/methods ; Genotype ; Humans ; Male ; Middle Aged ; Polymorphism, Single Nucleotide ; Risk

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Effects of 5-azacytidine on RUNX3 gene expression and the biological behavior of esophageal carcinoma cells.
Autorzy:: Wang S; Department of Thoracic Surgery, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China.
Liu H; Department of Otorhinolaryngology, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China.
Wang Z; Department of Thoracic Surgery, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China.
Chen HX; Department of Thoracic Surgery, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China.; Pokaż więcej
Źródło:: Molecular medicine reports [Mol Med Rep] 2014 Apr; Vol. 9 (4), pp. 1259-65. Date of Electronic Publication: 2014 Feb 11.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Azacitidine/*pharmacology
Core Binding Factor Alpha 3 Subunit/*genetics
Esophageal Neoplasms/*genetics
Gene Expression Regulation, Neoplastic/*drug effects
Animals ; Cell Line, Tumor ; Cell Movement/drug effects ; Cell Movement/genetics ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Cell Survival/genetics ; Core Binding Factor Alpha 3 Subunit/metabolism ; Esophageal Neoplasms/pathology ; Female ; Humans ; Male ; Methylation/drug effects ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Neoplasm Invasiveness ; Xenograft Model Antitumor Assays